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A previously reported blood pressure (BP) quantitative trait locus on rat Chromosome 1 was isolated in a
short congenic segment spanning 804.6 kb. The 804.6 kb region contained only two genes, LOC306664
and LOC306665. LOC306664 is predicted to translate into A Disintegrin-like and Metalloproteinase with
Thrombospondin Motifs-16 (Adamts16). LOC306665 is a novel gene. All predicted exons of both
LOC306664 and LOC306665 were sequenced. Non-synonymous variants were identiﬁed in only one of
these genes, LOC306664. These variants were naturally existing polymorphisms among inbred, outbred
and wild rats. The full-len g t hr a tt r a n s c r i p to fAdamts16 was detected in multiple tissues. Similar to
ADAMTS16 in humans, expression of Adamts16 was prominent in the kidney. Renal transcriptome analysis
suggested that a network of genes related to BP was differential between congenic and S rats. These genes
were also differentially expressed between kidney cell lines with or without knock-down of Adamts16.
Adamts16 is conserved between rats and humans. It is a candidate gene within the homologous region on
human Chromosome 5, which is linked to systolic and diastolic BP in the Quebec Family Study. Multiple var-
iants, including an Ala to Pro variant in codon 90 (rs2086310) of human ADAMTS16, were associated with
human resting systolic BP (SBP). Replication study in GenNet conﬁrmed the association of two variants of
ADAMTS16 with SBP, including rs2086310. Overall, our report represents a high resolution positional cloning
and translational study for Adamts16 as a candidate gene controlling BP.
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Essential hypertension (EH), is a very common condition
characterized by sustained high blood pressure (BP) with no
identiﬁable cause (1). Genetic susceptibility factors account
for 30% of an individual’s risk of developing EH (2).
Mapping experiments in humans have successfully identiﬁed
genetic determinants of rare, monogenic forms of hypertension
(3–11), but few have successfully deﬁned the major suscepti-
bility factors for EH, which represents 95% of all forms of
hypertension in humans. This void has a bearing on current
clinical management of EH, which is limited to symptomatic
treatment with select anti-hypertensive agents.
A genome-wide association study by The Wellcome Trust
Case Control Consortium (WTCCC) using 2000 cases of EH
and 3000 controls represents the single largest human
association study for hypertension conducted to date,
wherein six single-nucleotide polymorphisms (SNPs) were
reported as being associated with hypertension (12). Com-
parative mapping revealed that the homologous locations
of four out of these six human SNPs map within regions
of the rat genome identiﬁed as BP quantitative trait loci
(QTL) in our laboratory (Supplementary Material,
Table S1). Notably, among the many strain comparisons
that were used for mapping BP QTLs, all four regions are
reported as BP QTL containing regions originally identiﬁed
from a single linkage analysis between the hypertensive
Dahl Salt-sensitive (S) rat and the Lewis (LEW) rat (13).
Further, by combining transcriptional proﬁling with substi-
tution mapping of S and LEW rats, we prioritized Nr2f2
as a positional candidate locus for BP control (14), an obser-
vation that was corroborated recently in humans through a
haplotypic analysis of the WTCCC data (15). These obser-
vations support positional identiﬁcation of additional rat
BP loci previously detected through the genetic analysis of
Sa n dL E Wr a t s .
In this report, we focus on the ﬁne-mapping of one such BP
QTL (BP QTL2 on rat Chromosome 1) detected using S and
LEW rats (16). This BP QTL in rats is homologous to a BP
QTL detected on human Chromosome 5 in the Quebec
Family Study (QFS) (17).
Deriving and testing minimal congenic strains is a time-
consuming process. Several studies have inferred differential
segments between two congenic strains with opposite effects
as QTL containing regions (18–20). Further, multiple candi-
date genes with non-synonymous variants and/or differential
expression patterns are observed within QTL intervals (21–
23), which makes it difﬁcult to pin-point the actual genetic
determinant. In contrast to these scenarious, BP QTL2
region was isolated independently in a congenic strain. The
congenic interval spanned 804.6 kb and contained only two
expressed transcripts. Of these, DNA sequencing coupled
with transcript structure and expression analysis identiﬁed
Adamts16 as a candidate gene harboring non-synonymous var-
iants. ADAMTS16 is a member of a family of 19 secreted
metalloproteinases, whose function, in contrast to several
other family members, is unknown (24–26). There has been
very little prior characterization of ADAMTS16. It is highly
expressed in the kidney compared with other tissues (24),
but previous studies reported to date on ADAMTS16 have
not dealt with the kidney (24,27). Here we report that systolic
(SBP) and diastolic BP (DBP) were associated with SNPs of
ADAMTS16 in the QFS and in the GenNet study. This report
therefore provides the basis for further investigation of
ADAMTS16 as a novel gene involved in BP regulation.
RESULTS
Fine-mapping the BP QTL
The BP QTL described in this report, also called BP QTL
region 2 was previously ﬁne-mapped to a 2.73 Mb region
ﬂanked by the microsatellite markers D1Rat211 and
D1Rat12 (16). Figure 1 is a comprehensive representation
of markers genotyped for linkage analysis and for the con-
struction and characterization of congenic strains. The
detailed maps of the congenic substrains S.LEW
(D1Mco4x1x3B), S.LEW (D1Mco4x1x3Bx1) and S.LEW
(D1Mco4x1x3Bx2) are shown in Figure 2. The measured
BP of these congenic strains was signiﬁcantly lower (19, 18
and 14 mmHg, respectively) than that of the hypertensive S
rat as measured by the tail-cuff method (Table 1). The BP
of one of these strains, S.LEW (D1Mco4x1x3Bx1) was
additionally tested and corroborated by the telemetry
method (Fig. 3). The BP of the congenic strain S.LEW
(D1Mco4x1x3Bx1) was lower than that of the S at all
times, with the maximum difference between the two
groups observed during the ﬁrst 4 h of the resting phase.
The BP of the S at this phase was 216+8.6 mmHg com-
pared with that of the congenic strain 192+5.6 mmHg (BP
effect of 24 mmHg, P ¼ 0.03). Therefore, the smallest con-
genic interval shared by the congenic strains, S.LEW
(D1Mco4x1x3B), S.LEW (D1Mco4x1x3Bx1) and S.LEW
(D1Mco4x1x3Bx2), i.e. a fragment of 804597 bp ﬂanked by
D1MUO1 and D1MUO28, was inferred as adequate to
account for the effect of BP QTL2 (Fig. 1). Note that the
entire 804597 bp critical region is represented as congenic
intervals of two strains S.LEW (D1Mco4x1x3Bx1) and
S.LEW (D1Mco4x1x3Bx2). The data shown in Figure 1
compare the results of substitution mapping with those
obtained by genetic linkage analysis of the same region.
The location of the QTL determined by congenic strain
analysis is closer to one end of the LOD peak from linkage
analysis.
Clarifying the location of the BP QTL on Chromosome 1
As we were in the process of mapping this BP QTL, the
physical map location of the genomic segment from
D1Rat211-D1Rat12 was reported in the rat genome assem-
bly as located on rat Chromosome 17 (http://rgd.mcw.edu/
tools/genes/genes_view.cgi?id=1310046; www.ensembl.
org). As can be seen in Table 2, the physical locations of
the relevant markers in and around the 2.73 Mb BP QTL2
regions are distributed between rat Chromosomes 1 and
17. Genotyping data from our laboratory shows that this
fragment was incorrectly placed on the rat genome assem-
bly. It is currently placed towards the p-terminus of the
physical map of rat Chromosome 17, whereas, the correct
location of the critical 2.73 Mb BP QTL2 ﬂanked by
2826 Human Molecular Genetics, 2009, Vol. 18, No. 15D1Rat211 and D1Rat12 should be between the markers
D1Mco4 and D1Mco8 on rat Chromosome 1 (Fig. 1 and
Table 2). In agreement with our results, the Celera assembly
of the rat genome also indicated the location of the fragment
from D1Rat211-D1Rat12 as being on Chromosome 1 and
not on Chromosome 17.
Genomic composition of the 804.6 kb BP QTL containing
critical region
As a logical step after mapping to a 804.6 kb region, the
genomic content of this critical region of interest was exam-
ined and found to contain only two predicted genes,
Figure 1. Comprehensive representation of mapping BP QTL2. LOD plot for BP using the F2 (S x LEW) population (13) is shown at the top followed by the
congenic strains constructed to map the QTL to a 2.73 Mb region shown in red. Linkage map of Chromosome 1 is drawn to scale except for distances marked
with an asterisk. The current location of this region on the physical map of the rat genome is between the markers shown on the cytogenetic map of rat chromo-
some 17 (Both Ensembl and NCBI databases). Based on our data, it should lie within p11 of Chromosome 1, which is also shown in the diagram (Corroborated
by the Celera data on NCBI). All iterations of substitution mapping (16,32,47) are shown by congenic strains with BP lowering effect shown in green and the
ones without the BP lowering effect shown in gray. White boxes around the congenic strain schematics represent regions containing the recombination break-
point (crossover). The region highlighted in purple is the current ﬁne-mapped interval of 804.6 kb. The only two predicted genes within the critical interval are
indicated by blue arrows.
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proteinase with thrombospondin motif 16 (Adamts16) (24)
and LOC306665 (Figs 1 and 2). Adamts16 was predicted to
have 33 exons in earlier versions of the annotation of the rat
genome at NCBI, but only 23 exons are retained in the later
versions of the annotation. Nevertheless, we sequenced all
33 predicted exons of Adamts16 from S and LEW and detected
7 polymorphisms as shown in Figure 4 (labeled as transcript
locations 820, 1482, 1785, 1926, 2226, 2646 and 3508). Out
of these, only two were non-synonymous variants that resulted
in amino acid substitutions in the predicted mature polypep-
tide chain of Adamts16 from Pro274 and Thr1170 in LEW
rats to Ser274 and Ser1170 in S rats (Fig. 4). LOC306665
was also sequenced and no exonic non synonymous poly-
morphisms were detected.
Assessment of Adamts16 polymorphisms in inbred, outbred
and wild rats
Based on the analysis for all seven variants of Adamts16
detected in this study, inbred strains can be classiﬁed into
four different haplotypic groups (Supplementary Material,
Table S2). Out of the 21 inbred strains tested, the non-
synonymous SNPs (at þ820 and þ3508) of 8 strains were
similar to the S and 10 strains had the LEW variants
(Table 3). The remaining three strains had a combination of
the S and LEW variants at þ820 and þ3508. The non-
synonymous SNPs detected between S and LEW (at þ820
and þ3508) were additionally screened in other outbred and
wild rats. Outbred Sprague–Dawley rats represent the pro-
genitor group of rats from which the inbred S strain was
Figure 2. Congenic substrains used for locating the BP QTL. The relevant section of the physical map of RNO1 is shown on top of the Figure. Values in brackets
next to the marker names indicate their physical locations in base pairs on RNO1 (Celera). Values in parenthesis next to the marker names indicate their physical
locations in base pairs on RNO17 (NCBI). Information on the new polymorphic markers are available at our website: http://hsc.utoledo.edu/depts/physpharm/rat/
marker.html. The previously mapped BP RNO1 QTL2 region is shown as the orange bar. Congenic strains are shown as solid colored bars ﬂanked by open bars.
Solid green bars illustrate the LEW segment introgressed onto the background of S. The open bars at the end of each introgressed segment represent the region of
recombination. The BP effect is the BP of the congenic strain minus the BP of the control S. Independent t-tests were used to compare the means (P , 0.05). The
red rectangle represents the limits of Adamts16, whereas the blue rectangle represents the limits of LOC306665. Green tabs represent the chromosomal location
of SNPs polymorphic between S and LEW deposited in the Ensembl database (www.ensembl.org). ^ Novel polymorphic S and LEW SNPs identiﬁed by our
study.  Marker location reported by NCBI.
Table 1. Phenotypic effect of the QTL
Blood pressure (mmHg) Heart weight (mg)
S rat Congenic Effect P-value S rat Congenic Effect P-value
Congenic strain
S.LEW (D1Mco4x1x3B) 207 (4.7) 188 (3.5) 219 0.003 1321 (12.54) 1241 (11.86) 280 0.0001
S.LEW (D1Mco4x1x3Bx1) 190 (5.4) 172 (1.9) 218 0.005 1276 (17.25) 1201 (9.37) 275 0.0001
S.LEW (D1Mco4x1x3Bx2) 190 (5.4) 176 (2.2) 214 0.023 1276 (17.25) 1232 (17.05) 244 0.078
SBP data reported is from tail cuff determinations. Effect¼Congenic value 2S value; Negative values indicate a lower value in the congenic strain
compared with the S rat. Standard error of the means are in brackets; Number of rats in each group ranged from 18 to 30; all rats were males; In the
S.LEW (D1Mco4x1x3B) versus S comparison, rats were fed a 2% NaCl diet for 24 days starting at 40–42 days of age. In the other experiments shown in
the last two lines of the table, rats were maintained on a 0.3% NaCl diet and the same group of S rats were used as controls.
2828 Human Molecular Genetics, 2009, Vol. 18, No. 15derived. Heterozygosity of non-synonymous variants was
observed in both the outbred Sprague–Dawley and wild rats
tested (data not shown).
In addition to the S versus LEW combination, there are three
other strain combinations for which BP QTLs are reported
through linkage analysis in the same region (Fig. 5). The three
other strain comparisons, i.e. S versus BN, MNS versus MHS
andSHRversusF344,allrepresentcontrastingnon-synonymous
variants(at þ820and þ3508)similartotheSversusLEWcom-
parison. Thus, it is possible that S versus LEW is not the only
strain combination with variants of Adamts16 representing
candidates for the quantitative trait of BP.
Predicted transcript sequence, tissue distribution and
differential expression analysis of Adamts16
While attempting to translate the variants of Adamts16 from
the predicted transcript sequence from the NCBI website, we
noticed that the Ensembl website predicted a longer transcript,
which would potentially alter our inference on protein
translation. To test the validity of the transcript sequence pre-
diction of Adamts16 by the NCBI website, we sought to
amplify the expressed rat transcript of Adamts16 using
several sets of primers encompassing each of the transcript
sequence predictions (Fig. 6). We used these to amplify tran-
scripts from mixed pools of reverse-transcribed RNA from S
and LEW rats. Only one of the six primer combinations
tested resulted in a transcribed product of a size between
3000 and 4000 bp (Fig. 6). The PCR-ampliﬁed samples from
both S and LEW rats were cloned and sequence conﬁrmed
that the transcript of Adamts16 as predicted by NCBI, con-
sisted of 3666 bp (XM.225142). In concordance with
expression data of ADAMTS16 in humans (24), expression
of Adamts16 was prominent in the rat kidney, an organ most
relevant to the physiology of BP. Adamts16 was also detected
in other tissues including the thymus, lung, heart, liver and
spleen (Fig. 7). Real-time RT–PCR of kidney and heart
samples revealed that Adamts16 was not signiﬁcantly differen-
tially expressed in these organs between S and S.LEW
(D1Mco4x1x3Bx1) (data not shown). Expression of the
second candidate gene LOC306665 as determined by real-time
RT–PCR was also not different between kidney and heart
samples of S and S.LEW (D1Mco4x1x3Bx1) (data not
shown).
The predicted protein sequence described in our study is
translated from the validated transcript of Adamts16. The
nascent polypeptide chain coding for Adamts16 contains
Figure 3. BP effect of the QTL region detected by radiotelemetry. Nine S rats
(diamonds) and nine S.LEW (D1Mco4x1x3Bx1) congenic rats (squares) were
surgically implanted with the large C40 telemetry transmitters, allowed to
recover for a week and BP was recorded over a period of 4 days. The data
plotted is obtained by telemetry recording once every 5 min continuously
and averaged for 1 h intervals.
Table 2. Physical map locations of microsatellite markers that are linked to
RNO1 by genetic linkage analysis of F2 (S   LEW)
Microsatellite marker Genomic location
RNO17 (bp) RNO1 (bp)
D1Rat7 15999443
D1Rat153 21229309
D1Rat121 21288065
D1Got32 26956572
D1Got33 27326922
D1Got35 28864486
D1Mco4 29841429
D1Rat211 1147797
D1Rat239 1910351
D1MUO1 2374083 
D1MUO2 2398095 
D1Rat14 2480947
D1MUO24 3132997 
D1MUO27 3157205 
D1MUO28 3178680 
D1Arb5 3472897
D1Rat12 3643128
D1Mco8 33401356
D1Arb4 34480420
D1Rat11 34504757
D1Got40 35839844
D1Got46 38394290
D1Rat18 43747375
Microsatellite markers are those that are placed in order on the genetic
linkage map of F2 (S   LEW) (32).  Newly developed markers. Details of
these new markers are available at our website: (http://hsc.utoledo.edu/
depts/physiology/research/rat/marker.html). Additional markers on RNO1
are given in Figure 2. Start of the forward primer sequence on the physical
map locations on Chromosome 1 and 17 are given. These were obtained
from the rat genome sequence assembly 3.4 at the Ensembl website
(www.ensembl.org).
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amino acids reported for the human ortholog of Adamts16
(www.ncbi.nlm.nih.gov). Closer inspection of the primary
amino acid sequence indicated that the variant at location
274 in rat and the corresponding location of 277 in human
are within putative furin cleavage sites (Arg-Xaa-Arg/
Lys-Arg). ADAMTS proteases are synthesized as precursor
proteins (zymogens) that are proteolytically processed at
such consensus sites by furin to excise their propeptides. Pro-
peptide excision typically converts the zymogen to an active
protease. Therefore, the efﬁciency of cleavage of the variants
within this furin cleavage site of S and LEW was tested in a
protein construct containing the propeptide and catalytic
domains (Adamts16 Pro-Cat). However, there were no detect-
able differences in the efﬁciency of cleavage by furin (Sup-
plementary Material, Fig. S1). Next, we tested the possibility
that Adamts16 may function as a QTL gene that regulates
the expression of downstream ‘effector genes’, leading to a
Figure 4. Detection of variants of Adamts16 within the BP QTL region. Predicted candidate genes for the 2.73 Mb QTL interval are shown in the top panel of the
Figure as blue arrows within the region ﬂanked by the markers D1Rat211 and D1Rat12. This information was extracted from http://www.ncbi.nlm.nih.gov/
genome/guide/rat/index.html, Build 4.1. Arrows indicate the orientation of the gene sequence on the chromosome. The exons and introns of LOC306664,
which codes for Adamts16, are shown above the corresponding transcript sequence. Locations of transcript variants detected between S and LEW are numbered
on the transcript sequence. These transcript variations in S versus LEW are as follows: (i) T/C820, (ii) C/T1482, (iii) C/T1785, (iv) A/G1926, (v) T/C2226, (vi)
C/T2646, (vii) T/A3508. Resultant amino acid changes and their locations on the schematic diagram of the predicted polypeptide domain of Adamts16 are shown
at the bottom of the Figure. PLAC, protease and lacunin domain.
2830 Human Molecular Genetics, 2009, Vol. 18, No. 15physiological response related to BP control (28). To explore
the downstream genes and/or networks affected by Adamts16
polymorphisms, the renal transcriptomes of S and S.LEW
(D1Mco4x1x3Bx1) were analyzed. A total of 1294 differen-
tially expressed genes were identiﬁed (Supplementary
Material, Table S3). Of these genes, 256 were found to be dif-
ferentially expressed upon siRNA-mediated knock-down of
Adamts16 in rat kidney NRK-52E cells (Supplementary
Material, Table S4). This subset of 256 overlapping genes rep-
resents potential ‘effector genes’ regulated by Adamts16 (Sup-
plementary Material, Fig. S2). Successful knock-down of
Adamts16 was conﬁrmed by quantitative RT–PCR, where
Adamts16 mRNA levels in cells transfected with targeting
siRNAs were 32+4% of control cells transfected with non-
targeting siRNA (n ¼ 6, data not shown). Analysis of the
‘effector genes’ subset by Expression Analysis Systematic
Explorer (EASE) identiﬁed a number of gene ontologies of
potential interest in kidney function including regulation of
transcription, metal ion binding, extracellular space and
organ development (Supplementary Material, Fig. S2). Inter-
estingly and particularly relevant in this study was the identi-
ﬁcation of gene networks regulated by Adamts16 involved in
renal and urological disease which impacts on BP control
(Supplementary Material, Fig. S3) and in organ development
(Supplementary Material, Fig. S4).
Evidence for association of SNPs of ADAMTS16 in
human BP
To test whether ADAMTS16 is associated with human BP, we
sought populations in which evidence for linkage to BP or EH
was reported in the homologous region. There is one such
report in a non-obese subset of the QFS in which a homolo-
gous QTL for SBP was found (17). Consequently, twelve
known human ADAMTS16 SNPs were genotyped in 945 sub-
jects of this study. The LD plot for the associated SNPs is
shown in the Supplementary Material, Figure S5. Three
SNPs including an Ala to Pro variant in codon 90
(rs2086310) of human ADAMTS16 were associated with
human resting BP (Table 4). The association of the non-
synonymous variant rs2086310 within ADAMTS16 to SBP in
the QFS was conﬁrmed in the GenNet study with a total
sample size of 3205 (Table 4). The association of rs2086310
was observed in Whites but not in Blacks or Hispanics
(Table 4). Another SNP, rs2964433, was associated with
SBP in Whites and Hispanics and with DBP in Hispanics
only. Overall human variants were associated with lower
SBP and DBP.
DISCUSSION
The data presented is the result of sustained applications of
substitution mapping for over a decade and constitutes the
ﬁrst report of a BP QTL within a very short congenic
segment, containing variants within a single rat gene,
Adamts16. Similar associations of variants within human
ADAMTS16 that were prevalent in two independent popu-
lations provide the rationale for further functional analysis
of ADAMTS16 in the context of BP regulation and EH.
Additional replications would be required to conﬁrm these
associations in humans.
Previously we inferred that QTL2 was localized to a
2.73 Mb region on the basis of the differential segment
between two congenic strains, one with a BP effect and the
other without (16). By capturing the QTL in its entirety in
two congenic substrains, which can be considered as repli-
cated experiments, this QTL was shown to exert a phenotypic
effect independently, i.e. without genetic interaction from
introgressed LEW alleles of the previously reported strain
with the BP effect, S.LEW (D1Mco4x1x3A) (16).
Data presented in Figure 1 allowed us to compare the
results of substitution mapping to the evidence obtained
by genetic linkage analysis of the same region. It is interest-
ing to note that the location of the QTL gene under study
here is at some distance from the conﬁdence intervals of
LOD peaks for linkage to BP in the F2 (S   LEW) popu-
lation. This phenomenon is known from theoretical work
on simulations of linkage analysis involving two QTLs on
the same chromosome and the creation of a ‘ghost’ LOD
peak between them (29–31). This artifact occurs when
two QTLs are 40 cM apart and when the plus alleles at
both QTLs are on the same chromosome, and the contrast-
ing minus alleles are on the other chromosome. In the
present case, the two QTLs on rat Chromosome 1 [QTL2
under consideration here and another adjacent QTL called
QTL1 (32)] are conﬁgured such that the LOD peak is gen-
erated between them, rather than directly over either of
them. Other segregating populations, in which QTL1 is pre-
sumably not polymorphic, show excellent alignment of
QTL2 with the LOD peak (Fig. 5). The above situation
reiterates the difﬁculty of mapping QTL genes solely
based on linkage analysis as was often done in humans
and exempliﬁes the power of substitution mapping in
animal models to resolve QTLs by isolating them as ‘mono-
genic’ QTL effectors. The advantage of this approach is
shown by the data presented here, because the ﬁne-mapped
BP QTL did not contain any gene with previously known
function related to BP.
The accuracy of mapping QTLs and detecting underlying
genetic determinants depends heavily on the quality of assem-
bly of genomes and gene predictions. Early impediments to
the positional cloning effort described in this report included
Table 3. Predicted amino acids of the polypeptide chain of Adamts16 in 21 rat
inbred strains
AA
274
AA
1170
Number of inbred
strains
Inbred strains
Ser Ser 8 S, R, SHR, MHS, WKY, LH, LN, LL
Pro Thr 10 LEW, BN, MNS, F344, SBH, SBN,
AS, LOU, MWF, SJH
Pro Ser 3 ACI, DA, COP
AA, Amino acid; ACI, August   Copenhagen Irish; AS, Albino Surgery;
BN, Brown Norway; COP, Copenhagen; DA, Dark Agouti; F344, Fisher;
LEW, Lewis; LH, Lyon hypertensive; LL, Lyon hypotensive; LN, Lyon
normotensive; LOU, Louvain; MHS, Milan hypertensive strain; MNS,
Milan normotensive; MWF, Munich Wistar Fromter; R, Dahl
salt-resistant; S, Dahl salt-sensitive; SBH, Sabra hypertensive; SBN, Sabra
normotensive; SHR, spontaneously hypertensive rat; SJH, San Juan
hypertensive; WKY, Wistar Kyoto.
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some 17 and multiple, discordant gene predictions of
Adamts16. The data presented in Figure 1 and Table 2
resolved the error in sequence assembly by correctly placing
the region spanned by markers D1Rat211 and D1Rat12 on
Chromosome 1. Similarly, the biological data that we have
obtained allowed for solving the discrepancies among the
available predictions for gene and transcript sequences of rat
Adamts16. The most recent version of the predicted
Adamts16 gene at the NCBI rat genome resources website
(Build 4.1) concurs with the evidence that we have provided
in the present study.
It is interesting to note that in addition to other tissues,
Adamts16 is expressed in the kidney, which is a major organ
involved in BP homeostasis. The function of Adamts16 is
unknown (http://rgd.mcw.edu/tools/genes/genes_view.cgi?id=
1310046). Based on the roles of the ADAMTS family
members and based on the presence of a metalloproteinase
domain and intact active site sequence HESGHþHD within
Adamts16, it is likely that Adamts16 functions as a metallo-
proteinase in vivo. The non-synonymous SNPs reported in
this study do not reside within the metalloproteinase domain
of Adamts16. However, they are located in potentially critical
regions of the protease, since furin cleavage is known to
relieve enzyme latency of other members of the Adamts
family of proteins (33–38), and the thrombospondin repeat
domain is known to inﬂuence substrate binding and proteol-
ysis. As the SNPs within the nucleotides coding for the furin
cleavage site did not account for changes in efﬁciency of clea-
vage by furin, it is possible that the full-length protein may be
required for eliciting a differential functionality of Adamts16
variants. For example, a signal peptide mutation in
ADAMTS10 causing Weill–Marchesani syndrome was
found to have different effects on ADAMTS10 Pro-Cat and
full-length ADAMTS10 (39). Alternately, the ADAMTS16
thrombospondin-motifs, one of which is affected in the
second non-synonymous variant (þ3508), reported in our
study could have key biological activities. Since a substrate
is not known for Adamts16, these possibilities are currently
unexplored and beyond the scope of the present work. Regard-
Figure 5. Comparisons of linkage maps of Chromosome 1. Individual Figures of linkage data for BP extracted from the published data of crosses shown in
Green. Colored arrows show the relative location of Adamts16.
2832 Human Molecular Genetics, 2009, Vol. 18, No. 15less of the functional alterations, we hypothesized that altera-
tions of the renal transcriptome as a consequence of altered
functions of Adamts16 could be important in understanding
the potential link between the mechanism of action of this
gene product and the physiology of BP regulation. Because
the renal transcriptome of the congenic strain may not be
the exclusive representation of the downstream effectors regu-
lated by Adamts16, but may rather represent the net effect of
the introgressed congenic segment, we compared the results
of our study to the ‘biological signature’ obtained by knock-
down of Adamts16. Overlapping, multiple networks related
to BP and organogenesis were perturbed in both cases. The
precise mechanism through which such changes in expression
lead to the alteration in BP remains to be determined in this
model. The results suggested interesting gene targets for BP
regulation such as histone deacetylases Hdac5 and Hdac10,
genes involved in epigenetic regulation. Taken together, the
results are highly supportive of the kidney as one of the
Figure 6. Adamts16 predicted transcript analysis. (A) Schematic representations of previous and current NCBI and Ensembl annotations for Adamts16
(LOC306664). Primers were designed at the locations speciﬁed as (A) through (E) in the directions depicted by the arrows. All primers are 50-30: Primer
A ¼ ATGGAACCCCGCGGTTGC, Primer B ¼ ATGGGAGCCAATGCAAATGTATAC, Primer C ¼ TGAAGATATTTCCAAATGTCCTCC, Primer D ¼
CTCACAGGTTGGACTTGGAAC, Primer E ¼ CTACTTTAGAACTCGGTGGTTG. (B) Ethidium bromide stained agarose gel of PCR products obtained
from a mixed pool of either S or LEW cDNA and different combinations of primer pairs. The combinations of primers are as follows (S, S rat mixed
cDNA pool; L, LEW rat mixed cDNA pool). Only the primer A þ E combination gave a product with an approximate size of 3700 bp. (C) Schematic represen-
tation of the cloned Adamts16 transcript (both the S and LEW RT–PCR reactions yielded a gene with 3666 bp, coding for 23 exons that translate into 1221
amino acids).  Location of the initiation codon;   location of the termination codon; ^location of start of transcription; M, molecular weight marker.
Human Molecular Genetics, 2009, Vol. 18, No. 15 2833sites of action through which variants of Adamts16 participate
in the regulation of BP.
Considering the difﬁculty of deﬁning what constitutes a
good standard for identifying a gene underlying a QTL,
Glazier et al. have suggested some criteria (40). In a recent
review on the genetic dissection of hypertension (41),
Cowley indicated that the gold standard for validation of a
potential candidate gene for hypertension is that the rescue
of the phenotype must be done in the same species and with
the same genetic background that was used to identify the
QTL. Our study almost meets this ‘gold standard’ because
(i) The QTL is ﬁne-mapped to a small region solely based
on natural recombination events, thus closely mimicking the
performance of a natural allele in the rat as opposed to artiﬁ-
cially genetically manipulated systems such as transgenics and
knock-ins; and (ii) we are able to map the QTL to a gene-
sparse region as conﬁrmed by comparative mapping in rats,
mice and humans (16), thus allowing for testing of the two
expressed candidate transcripts, only one of which had
coding sequence variants. One could argue that in addition
to the variants within Adamts16, there may be other variants
within inter-genic or intra-genic regions of the critical QTL
interval that contribute to the QTL effect. Like in any pos-
itional cloning study, regardless of any criteria, such possibili-
ties cannot be ruled out. However, with the view of improving
the clinical management strategies for high BP through the
identiﬁcation of novel and effective drug targets, the current
study in rats as model organisms with follow-up analyses in
independent association studies in humans from two unrelated
populations, provide the rationale for prioritization of func-
tional studies of ADAMTS16 as a candidate for the BP QTL
on human Chromosome 5.
MATERIALS AND METHODS
Animals
All animal experiments were conducted as per pre-approved
protocols by the Institutional animal care and use committee
(IACUC) of the University of Toledo College of Medicine
(UTCOM). Dahl salt-sensitive (SS/Jr) inbred rats were from
our colony maintained at UTCOM. LEW/NCrlBR (LEW rat)
was originally obtained from the Charles River Laboratories
(Wilmington, MA) and maintained in our colony. The con-
genic substrain S.LEW (D1MCO4X1X3B) was derived from
S.LEW (D1MCO4X1) (16) as the parental strain contributing
to the introgressed LEW alleles. Congenic substrains S.LEW
(D1MCO4X1X3BX1) and S.LEW (D1MCO4X1X3BX2)
were derived from S.LEW (D1MCO4X1X3B) as the progeni-
tor with LEW alleles at the QTL region. The congenic sub-
strains were constructed by crossing the progenitor congenic
strain to the S rat to obtain a heterozygous F1 population.
An F1   F1 intercross then yielded an F2 population. The
F2 animals were selected for recombinants with varying
sizes of the LEW RNO1 introgressed region. A new recombi-
nant animal was backcrossed to S rats to duplicate the new
recombinant chromosome. The resulting progeny were geno-
typed to identify heterozygotes. Heterozygotes were then
intercrossed to produce progeny, which were screened for
animals homozygous for the new recombinant chromosome.
Finally, the homozygous animals were bred to generate a con-
genic strain containing the desired LEW chromosomal
segment in the homozygous form on the S genetic back-
ground.
Microsatellite marker development and tracking
recombination events in congenic strains
Microsatellite repeats in the region of interest were identiﬁed
on the rat genomic sequence (version 3.1) at the NCBI website
(www.ncbi.nlm.nih.gov). In order to amplify these microsatel-
lite repeats, primers were designed using the Primer3 software
available at the website: http://frodo.wi.mit.edu/cgi-bin/
primer3/primer3_www.cgi and synthesized by integrated
DNA technologies (IDT) (www.idtdna.com). DNA was iso-
lated with the QIAamp Tissue Kit (Qiagen Inc.) from S,
LEW and congenic substrains. PCR reactions were set up
using the primers designed to amplify microsatellite repeats
from S and LEW rats. Polymorphic repeats were used as
markers to genotype DNA from tail biopsies of the relevant
rat populations.
Predicted genomic and transcript analysis
Predicted gene sequences within the QTL region were down-
loaded from the rat genome sequence at the NCBI website
(www.ncbi.nlm.nih.gov). Primers to amplify exons were
designed using the ExonPrimer software (http://ihg.gsf.de/
ihg/ExonPrimer.html). Primers tagged with M-13 sequences
were synthesized by IDT. All primer sequences mentioned
in our work are available at our website (http://
hsc.utoledo.edu/depts/physiology/research/rat/). Genomic
DNA was ampliﬁed using these primers and sequenced by
MWG Biotech Inc. Predicted transcript sequences were
extracted from the NCBI database and/or Ensembl
(www.ensembl.org). Primers were designed encompassing
the start and stop codons of each predicted transcript using
Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_
www.cgi) or Oligonucleotide properties calculator (http://
Figure 7. Tissue distribution of Adamts16. Various tissues from one S and one
S.LEW (D1Mco4x1x3Bx1) congenic rat (labeled as S.L) were collected after
euthanization of the rats by CO2 inhalation. Total RNA was extracted from the
tissues using the Trizol reagent (Invitrogen). Three microgram of RNA from
each tissue obtained from either an S or S.LEW (D1Mco4x1x3Bx1) (3
months old) maintained on 0.3% NaCl containing diet was reverse transcribed
using Superscript III (Invitrogen). Resultant cDNA was ampliﬁed by multi-
plexing PCR for both Adamts16 and beta-actin using the following four
primers in the same reaction: Primers for Adamts16: (i)
50-TTGCTTTGCGCTCTGGGT-3’; (ii) 50-AGAAAGGGCCACAGAAGAA-
3’ and primers for beta-actin; (iii) 50-GTGTGATGGTGGGTATGG-3’ and
(iv) 50-CGCGTAACCCTCATAGAT-3’. PCR products were resolved on a
3% agarose gel.
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senger RNA from various tissues of S and LEW were
extracted using TRIzol Reagent (Life Technologies). cDNA
of the predicted transcripts within the QTL region was
obtained by reverse transcription using the SuperScript III
First-Strand Synthesis System for RT–PCR (Invitrogen).
Standard polymerase chain reaction, using Platinum Taq
DNA Polymerase High Fidelity (Invitrogen) and gene-speciﬁc
primers, was used to amplify the cDNA. S and LEW gene
amplicons were cloned into the Topo-TA-Cloning System
(Invitrogen) as per the manufacture’s recommended pro-
cedures. Plasmid DNA was puriﬁed using the QIAprep-
miniprep (Qiagen). The full-length S and LEW alleles for
each gene within the QTL region were sequenced by MWG
(High Point, NC), using vector-based and gene-speciﬁc
primers. All sequence data were analyzed using DNA Star
(DNAStar Inc.) and/or Sequencher (Genecodes Corp.).
BP measurements
Each set of congenic substrains (n ¼ 20 males) and control S
rats (n ¼ 20 males) were bred, housed and studied concomi-
tantly to minimize environmental effects. Rats were weaned
at 30 days of age and given a low salt diet (0.4% NaCl,
Harlan Teklad). At 40–42 days of age rats on a high salt
dietary study only were fed 2% NaCl diet (Harlan Teklad
diet TD94217) for 24 days. Rats on a low salt dietary study
were continued on the 0.4% NaCl in their diet. SBP was
measured using the tail-cuff method commencing on the
25th day (42). Brieﬂy, conscious restrained rats were
warmed to 288C. The BP of each rat was measured for four
consecutive days by two blinded operators. BP values for
each day were the mean of three to four consistent readings.
The ﬁnal BP value used was the mean of the four daily BP
values. The day after the last BP measurements, rats were
euthanized and heart weights were recorded. BP was also col-
lected using a telemetry system (Data Sciences International,
St. Paul, MN) as explained in detail previously (16). Brieﬂy,
4 days after the BP measurements by the tail-cuff method,
rats S (n ¼ 9) and congenic rats (n ¼ 9) on a low salt diet
were surgically implanted with a transmitter into the left
ﬂank and the probe was inserted through the femoral artery
and advanced to the lower abdominal aorta. Rats were
allowed to recover from surgery for a week before the trans-
mitters were turned on and BP data collected for 24 h at a
time over several weeks. All statistical analyses were per-
formed as previously reported (16), using SPSS software.
Transcriptome and network analyses
Gene expression analysis was carried out on the Rat Genome
230 version 2 GeneChip as recommended by the manufacturer
(Affymetrix, Santa Clara, CA). Hybridizations were per-
formed to compare the transcriptome in hypertensive S rat
kidney (three independent hybridizations from individual
animals) versus S.LEW (D1Mco4x1x3Bx1) congenic rat
Table 4. Human Adamts16 variants with associations to SBP and DBP in the QFS and GenNet study
Study Variant Genotype n SBP P1 P2 DBP P1 P2
QFS rs1871468 C/C 654 115.7+0.6 ns 0.0024 71.5+0.4 0.0002 0.0019
C/G 165 114.1+1.1 69.4+0.7
G/G 7 106.4+2.2 68.9+1.3
QFS rs2086310 G/G 587 116.0+0.6 0.009 0.0025 71.6+0.5 0.006 0.0008
C/G 210 114.2+0.9 70.1+0.5
C/C 14 106.5+2.1 67.1+1.5
QFS rs10512769 C/C 596 115.8+0.6 0.06 0.0004 71.6+0.4 0.0005 0.0027
C/T 205 114.3+1.2 69.6+0.7
T/T 27 108.4+2.3 69.8+1.4
GenNet (Whites) rs2086310 G/G 975 123.7+0.6 0.01 0.02 76.8+0.4 ns ns
C/G 434 120.9+0.8 75.7+0.5
C/C 56 124.5+2.9 76.1+1.44
GenNet (Whites) rs2964433 G/G 1062 123.2+0.5 0.01 0.009 76.6+0.3 ns ns
A/G 357 123.0+0.9 76.6+0.6
A/A 30 112.5+1.7 72.2+1.7
GenNet (Blacks) rs2086310 G/G 409 122.8+0.9 ns ns 76.3+0.7 ns ns
C/G 434 122.6+0.9 75.6+0.7
C/C 105 124.1+1.8 75.7+1.4
GenNet (Blacks) rs2964433 G/G 776 122.5+0.7 ns ns 75.6+0.5 0.07 0.08
A/G 159 123.6+1.4 77.6+1.1
A/A 9 127.1+6.6 79.2+2.7
GenNet (Hispanics) rs2086310 G/G 610 112.6+0.8 ns ns 69.5+0.5 ns ns
C/G 169 113.7+1.4 69.8+0.8
C/C 8 110.2+3.7 64.5+2.6
GenNet (Hispanics) rs2964433 G/G 633 113.1+0.8 ,0.0001 ,0.0001 69.6+0.5 ,0.0001 ,0.0001
A/G 90 108.4+1.7 67.5+1.1
A/A 2 104.2+0.4 66.2+0.3
Values for SBP and DBP are Means+SEM after adjustment for age, sex, sodium intake and waist circumference. DBP, diastolic blood pressure; SBP,
systolic blood pressure; P1, P-values for age- and sex-adjusted data; P2, P-values for data adjusted for age, sex, sodium intake and waist circumference.
ns, non signiﬁcant. QFS, Quebec family study; GenNet, one of four multicenter networks investigating blood pressure genetics.
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targeting siRNA versus two different Adamts16-targeting
siRNAs transfected into rat kidney NRK-52E cells (three inde-
pendent transfections for control, two independent transfec-
tions for each targeting siRNA). siRNAs were transfected
into cells with DharmaFECT reagent (Dharmacon) for 48 h
prior to RNA isolation. The control siRNA is a non-sense
sequence with no human GenBank database match (sense
sequence: 50-CCTCCAATGTGCTCGGTAAT-30), and two
Adamts16-targeting siRNAs were separately employed to
account for potential off-target effects (sense sequences:
50-AGAAGTACGTCTCCGGAAA-30 and 50-CCTATATTTC
TGTGCGCAA-30). Gene expression data ﬁles were processed
and scaled with the Affymetrix GeneChip Operating Software.
Statistical analysis for differential gene expression was accom-
plished by an analysis of variance with 10% false discovery
rate to control for type I error resulting from multiple compari-
sons. All data are accessible at the GEO database (http://
www.ncbi.nlm.nih.gov/geo/) with the accession number
GSE12869. Gene ontologies, gene networks and canonical
pathways were investigated using EASE (43), Ingenuity
Pathway Analysis (IPA, www.ingenuity.com, Redwood City,
CA), Pathway Studio (www.ariadnegenomics.com), the GO
Consortium (www.geneontology.org), GenMAPP (www.
genmapp.org) and Kyoto Encyclopedia of Genes and
Genomes (www.genome.jp/kegg).
Furin cleavage assay. The S and LEW alleles of the 1.6 kb
fragment encoding the furin cleavage site along with the pro-
peptide and catalytic domains (Adamts16 Pro-Cat) was ampli-
ﬁed by PCR and subcloned into the Not1 and BamH1
restriction endonuclease sites of the pcDNA3.1/myc-HIS
vector. Primer sequences for ampliﬁcation of the S and
LEW alleles are 50-GCT AGC TAT ATA GCG GCC GCC
ACC ATG GAA CCC CGC GG-30 and 50-TAG AAA GCT
TGG TAC CGA GCT CGG ATC CAG CTT TTC CGG
GTA CTT GTA-30. Ampliﬁed products were sequence veriﬁed
by bidirectional dideoxy sequencing. Furin cleavage assay was
performed as described in the legend to Supplementary
Material, Figure S1.
Association studies in humans
Quebec family study. The QFS is composed of French Cana-
dian families from the greater Quebec City area recruited
through the media between 1978 and 1981 (Phase 1), 1989
and 1994 (Phase 2) and 1995 and 2001 (Phase 3). The QFS
study represents a mixture of random sampling (Phase 1)
and ascertainment through and obese proband (Phases 2 and
3), as described previously (44). The present analyses are
based on participants from phases 2 and 3 not taking anti-
hypertensive drug and include a total of 854 individuals
(373 men and 481 women) from 220 families. The Medical
Ethics Committee of Laval University approved the protocol
and all participants gave their written consent to participate
in the study.
All exonic ADAMTS16 SNPs (ﬁve total) as well as seven
SNPs in the vicinity of exons with conﬁrmed minor allele fre-
quency of 10% or greater in Caucasians were genotyped in the
QFS. Genotyping of the SNPs was done by the primer exten-
sion method with ﬂuorescence polarization detection (FP-TDI;
PerkinElmer Inc.) (45). Changes in ﬂuorescence polarization
after excitation of the samples by plane-polarized light were
measured using a Victor2 Plate Reader (Perkin Elmer Life
Sciences). The allele calling was performed with the SNP
scorer genotyping software (Perkin Elmer Life Sciences).
Details for PCR conditions and primer sequences are available
upon request at rankint@pbrc.edu.
GenNet study. The GenNet study comprises 3467 individuals
in total, recruited between 1995 and 2004 [1101 African
Americans (AA), 839 Hispanic Americans (HA) and 1496
European Americans (EA)] (46). Individuals were recruited
at two ﬁeld centers: EA were recruited from Tecumseh, Michi-
gan, and AA and HA were recruited from Maywood, IL.
Recruitment was performed in families starting from a
proband with high BP. DNA was available for 3205 individ-
uals (968 AA, 824 HA and 1471 EA). Measured SBP and
DBP (average over two manual measurements) was adjusted
for age and sex, or age, sex and BMI, by linear regression
and the residuals were used in the analysis. The impact of anti-
hypertensive therapy on BP levels was empirically corrected
for by adding 10 mmHg to SBP and 5 mmHg to DBP if a par-
ticipant took BP-lowering medications.
SNP genotyping in the GenNet study. SNP genotyping was
performed on all DNA samples available and genotypes
could be obtained from using a 50-nuclease-based assay
(TaqMan, ABI) analyzed on an ABI Prism 7900 Real Time
PCR System according to the manufacturer’s instructions.
Call rates were 0.989 for rs2086310 and 0.982 for
rs2964433. There was no evidence for deviation from
Hardy–Weinberg equilibrium within each ethnic group (P .
0.1 for all populations in both variants tested). As additional
quality control, we produced duplicate genotypes (n ¼ 102)
that gave identical results and genotypes from seven
HapMap samples that were all consistent with the HapMap
dataset. Minor allele frequencies were 0.3, 0.188, 0.129 (rs
2086310) and 0.1, 0.134, 0.043 (rs2964433) for AA, EA and
HA, respectively.
Analyses: QFS and GenNet study. Association testing for
measured SBP and DBP (average over two manual measure-
ments) was performed with a mixed regression model using
the SAS PROC MIXED procedure (version 9.1.3; SAS Insti-
tute, Cary, NC). The non-independence of the data resulting
from the familial structure in GenNet and QFS was accounted
for in the analyses by using a sandwich procedure which
asymptotically yields the same parameter estimates as an
ordinary least squares or regression method but the standard
errors and consequently hypothesis tests are adjusted for the
dependencies. Two sets of analyses were performed, one on
age- and sex-adjusted data and a second one adjusted for
age, sex and BMI (for GenNet) and for age, sex, sodium
intake and waist circumference (for QFS). In GenNet, the
impact of anti-hypertensive therapy on BP levels was empiri-
cally corrected for by adding 10 mmHg to SBP and 5 mmHg
to DBP if a participant took BP-lowering medications.
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